IL17A and endometrial cancer: IL-17, as a potent pro-inflammatory cytokine, is closely associated with the formation, growth, and metastasis of various tumors, promoting tumor growth by activating proliferation-related pathways in endometrial cancer cell [39], such as NF-κB and STAT3.